| Neurological and neuropsychiatric complications of COVID-19 in 153 patients: a UK-wide surveillance study A Varatharaj, N Thomas, MA Ellul, NWS Davies, TA Pollak, EL Tenorio, ... The Lancet Psychiatry 7 (10), 875-882, 2020 | 1538 | 2020 |
| Plasma antioxidants are similarly depleted in mild cognitive impairment and in Alzheimer’s disease P Rinaldi, MC Polidori, A Metastasio, E Mariani, P Mattioli, A Cherubini, ... Neurobiology of aging 24 (7), 915-919, 2003 | 749 | 2003 |
| Conversion of MCI to dementia: role of proton magnetic resonance spectroscopy A Metastasio, P Rinaldi, R Tarducci, E Mariani, FT Feliziani, A Cherubini, ... Neurobiology of aging 27 (7), 926-932, 2006 | 150 | 2006 |
| Reduction in ventral striatal activity when anticipating a reward in depression and schizophrenia: a replicated cross-diagnostic finding G Arrondo, N Segarra, A Metastasio, H Ziauddeen, J Spencer, ... Frontiers in psychology 6, 1280, 2015 | 148 | 2015 |
| The epidemiology of first-episode psychosis in early intervention in psychosis services: findings from the social epidemiology of psychoses in East Anglia [SEPEA] study JB Kirkbride, Y Hameed, G Ankireddypalli, K Ioannidis, CM Crane, ... American Journal of Psychiatry 174 (2), 143-153, 2017 | 135 | 2017 |
| Ethnic minority status, age-at-immigration and psychosis risk in rural environments: evidence from the SEPEA study JB Kirkbride, Y Hameed, K Ioannidis, G Ankireddypalli, CM Crane, ... Schizophrenia Bulletin 43 (6), 1251-1261, 2017 | 112 | 2017 |
| Abnormal frontostriatal activity during unexpected reward receipt in depression and schizophrenia: relationship to anhedonia N Segarra, A Metastasio, H Ziauddeen, J Spencer, NR Reinders, ... Neuropsychopharmacology 41 (8), 2001-2010, 2016 | 101 | 2016 |
| Olanzapine as the ideal “trip terminator”? Analysis of online reports relating to antipsychotics' use and misuse following occurrence of novel psychoactive substance‐related … G Valeriani, O Corazza, FS Bersani, C Melcore, A Metastasio, G Bersani, ... Human Psychopharmacology: Clinical and Experimental 30 (4), 249-254, 2015 | 60 | 2015 |
| Acute D3 antagonist GSK598809 selectively enhances neural response during monetary reward anticipation in drug and alcohol dependence A Murphy, LJ Nestor, J McGonigle, L Paterson, V Boyapati, KD Ersche, ... Neuropsychopharmacology 42 (5), 1049-1057, 2017 | 49 | 2017 |
| The Imperial College Cambridge Manchester (ICCAM) platform study: an experimental medicine platform for evaluating new drugs for relapse prevention in addiction. Part A: study … LM Paterson, RSA Flechais, A Murphy, LJ Reed, S Abbott, V Boyapati, ... Journal of Psychopharmacology 29 (9), 943-960, 2015 | 47 | 2015 |
| Brain structural signatures of negative symptoms in depression and schizophrenia JY Chuang, GK Murray, A Metastasio, N Segarra, R Tait, J Spencer, ... Frontiers in psychiatry 5, 116, 2014 | 44 | 2014 |
| Interaction of CTSD and A2M polymorphisms in the risk for Alzheimer's disease E Mariani, D Seripa, T Ingegni, G Nocentini, F Mangialasche, S Ercolani, ... Journal of the neurological sciences 247 (2), 187-191, 2006 | 43 | 2006 |
| Transitioning bodies. The case of self-prescribing sexual hormones in gender affirmation in individuals attending psychiatric services A Metastasio, A Negri, G Martinotti, O Corazza Brain sciences 8 (5), 88, 2018 | 41 | 2018 |
| Proton magnetic resonance spectroscopy reveals similar white matter biochemical changes in patients with chronic hypertension and early Alzheimer's disease M Catani, P Mecocci, R Tarducci, R Howard, GP Pelliccioli, E Mariani, ... Journal of the American Geriatrics Society 50 (10), 1707-1710, 2002 | 41 | 2002 |
| Social and spatial heterogeneity in psychosis proneness in a multilevel case–prodrome–control study JB Kirkbride, J Stochl, J Zimbrón, CM Crane, A Metastasio, E Aguilar, ... Acta Psychiatrica Scandinavica 132 (4), 283-292, 2015 | 28 | 2015 |
| Neurological and neuropsychiatric complications of COVID-19 in 153 patients: a UK-wide surveillance study. Lancet Psychiatry 7: 875–882 A Varatharaj, N Thomas, MA Ellul, NWS Davies, TA Pollak, EL Tenorio, ... Link: https://bit. ly/3nroFha, 2020 | 23 | 2020 |
| Synthetic cannabinoid use in a case series of patients with psychosis presenting to acute psychiatric settings: clinical presentation and management issues S Bonaccorso, A Metastasio, A Ricciardi, N Stewart, L Jamal, NUD Rujully, ... Brain Sciences 8 (7), 133, 2018 | 21 | 2018 |
| Clozapine, neutropenia and Covid-19: should clinicians be concerned? 3 months report S Bonaccorso, A Ricciardi, S Ouabbou, C Theleritis, A Ross-Michaelides, ... Brain, Behavior, & Immunity-Health 13, 100212, 2021 | 20 | 2021 |
| Can Kratom (Mitragyna speciosa) Alleviate COVID-19 Pain? A Case Study A Metastasio, E Prevete, D Singh, O Grundmann, WC Prozialeck, C Veltri, ... Frontiers in psychiatry 11, 594816, 2020 | 20 | 2020 |
| Novel psychoactive substances in custodial settings: a mixed method investigation on the experiences of people in prison and professionals working with them O Corazza, S Coloccini, S Marrinan, M Vigar, C Watkins, C Zene, A Negri, ... Frontiers in psychiatry 11, 460, 2020 | 18 | 2020 |
Patrizia MecocciSezione di Gerontologia e Geriatria, Dipartimento di Medicina e Chirurgia, Università di Perugia在 unipg.it 的电子邮件经过验证
